Conclusion:-
In conclusion, Takayasu arteritis presents with a heterogeneous clinical
profile, involving multiple organ systems. The non-specific nature of
symptoms and the potential overlap with other conditions pose challenges
for diagnosis. It is crucial for clinicians to maintain a high index of
suspicion, particularly in young females presenting with symptoms such
as headache, vision problems, dizziness, and upper extremity fatigue.
Early recognition, appropriate diagnostic evaluation, and timely
initiation of treatment are paramount to improve patient outcomes and
prevent complications associated with Takayasu arteritis. Further
research is needed to enhance our understanding of the disease and
develop more effective diagnostic and treatment strategies.
REFERENCES:-
1. De Souza AWS, de Carvalho JF. Diagnostic and classification criteria
of Takayasu arteritis. J Autoimmun . 2014;48-49:79-83.
doi:10.1016/J.JAUT.2014.01.012
2. Mason JC. Takayasu arteritis–advances in diagnosis and management.Nat Rev Rheumatol . 2010;6(7):406-415. doi:10.1038/NRRHEUM.2010.82
3. Nakagomi D, Jayne D. Outcome assessment in Takayasu arteritis.Rheumatology . 2016;55(7):1159-1171.
doi:10.1093/RHEUMATOLOGY/KEV366
4. Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz
S, Espino Vela J. Takayasu’s arteritis. Clinical study of 107 cases.Am Heart J . 1977;93(1):94-103. doi:10.1016/S0002-8703(77)80178-6
5. Subramanyan R, Joy J, Balakrishnan KG. Natural history of
aortoarteritis (Takayasu’s disease). Circulation .
1989;80(3):429-437. doi:10.1161/01.CIR.80.3.429
6. Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu
arteritis. A study of 32 North American patients. Medicine
(Baltimore) . 1985;64(2):89-99. doi:10.1097/00005792-198503000-00002
7. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis.Ann Intern Med . 1994;120(11):919-929.
doi:10.7326/0003-4819-120-11-199406010-00004
8. Jain S, Kumari S, Ganguly NK, Sharma BK. Current status of Takayasu
arteritis in India. Int J Cardiol . 1996;54 Suppl(S2):S111-S116.
doi:10.1016/S0167-5273(96)88780-8
9. Mwipatayi BP, Jeffery PC, Beningfield SJ, et al. Takayasu arteritis:
clinical features and management: report of 272 cases. ANZ J
Surg . 2005;75(3):110-117. doi:10.1111/J.1445-2197.2005.03312.X
10. Andrews J, Mason JC. Takayasu’s arteritis–recent advances in
imaging offer promise. Rheumatology (Oxford) . 2007;46(1):6-15.
doi:10.1093/RHEUMATOLOGY/KEL323
11. Blockmans D, Bley T, Schmidt W. Imaging for large-vessel vasculitis.Curr Opin Rheumatol . 2009;21(1):19-28.
doi:10.1097/BOR.0B013E32831CEC7B
12. Meller J, Strutz F, Siefker U, et al. Early diagnosis and follow-up
of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol
Imaging . 2003;30(5):730-736. doi:10.1007/S00259-003-1144-Y
13. Andrews J, Al-Nahhas A, Pennell DJ, et al. Non-invasive imaging in
the diagnosis and management of Takayasu’s arteritis. Ann Rheum
Dis . 2004;63(8):995-1000. doi:10.1136/ARD.2003.015701
14. Ito I. Medical treatment of Takayasu arteritis. Heart Vessels
Suppl . 1992;7(1 Supplement):133-137. doi:10.1007/BF01744559
15. Hoffman GS. Takayasu arteritis: lessons from the American National
Institutes of Health experience. Int J Cardiol . 1996;54
Suppl(S2):S99-S102. doi:10.1016/S0167-5273(96)88778-X
16. Hoffman GS, Ahmed AE. Surrogate markers of disease activity in
patients with Takayasu arteritis. A preliminary report from The
International Network for the Study of the Systemic Vasculitides
(INSSYS). Int J Cardiol . 1998;66 Suppl 1(SUPPL. 1).
doi:10.1016/S0167-5273(98)00181-8
17. Noel N, Butel N, Le Hoang P, et al. Small vessel involvement in
Takayasu’s arteritis. Autoimmun Rev . 2013;12(3):355-362.
doi:10.1016/J.AUTREV.2012.05.010